References
- Chung H, Kim B, Jung SH, et al. 2013. Does phosphorylation of cofilin affect the progression of human bladder cancer?BMC Cancer 13:45.
- Leu JD, Chiu YW, Lo CC, et al. 2013. Enhanced cellular radiosensitivity induced by cofilin-1 over-expression is associated with reduced DNA repair capacity. International Journal of Radiation Biology 89:433–444.
- Li M, Yin J, Mao N, Pan L. 2013. Upregulation of phosphorylated cofilin 1 correlates with taxol resistance in human ovarian cancer in vitro and in vivo. Oncology Reports 29:58–66.
- Nishimura S, Tsuda H, Kataoka F, et al. 2011. Overexpression of cofilin 1 can predict progression-free survival in patients with epithelial ovarian cancer receiving standard therapy. Human Pathology 42:516–521.
- Pérez-Martinez FC, Carrión B, Lucio MI, et al. 2012. Enhanced docetaxel-mediated cytotoxicity in human prostate cancer cells through knockdown of cofilin-1 by carbon nanohorn delivered siRNA. Biomaterials 33:8152–8159.
- Ren S, Ouyang DY, Saltis M, et al. 2012. Anti-proliferative effect of 23,24-dihydrocucurbitacin F on human prostate cancer cells through induction of actin aggregation and cofilin-actin rod formation. Cancer Chemotherapy and Pharmacology 70:415–424.
- Zhou J, Wang Y, Fei J, Zhang W. 2012. Expression of cofilin 1 is positively correlated with the differentiation of human epithelial ovarian cancer. Oncology Letters 4:1187–1190.